×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Welcome & Keynote: Diversity, Equity, and Inclusion in the R&D Space
Session Chair(s)
Fadwa Almanakly, PharmD
Vice President & Head, Advertising and Promotion, Regulatory Affairs Americas
Bayer Pharmaceuticals, United States
Sheetal Patel, PharmD
Vice President, Specialty Compliance
Johnson & Johnson, United States
At the heart of our work, we all share the same priority which is the wellbeing of the patients we serve. Therefore, there is a need for selecting a diverse group of patients to share their personal health journey highlighting the need for integrating patient diversity from the start. The keynote will discuss the importance of diversity throughout the drug development lifecycle.
Learning Objective : At the conclusion of this session, participants should be able to:- Discuss FDA’s expectations based on their draft guidance for Diversity & Inclusion in Clinical Trials
- Recognize the importance of recruiting hard-to-reach populations
- Apply lessons and recommendations to lead a successful inclusive, multicultural marketing campaign
Speaker(s)
Speaker
Jen Horonjeff, PhD
Savvy Cooperative, United States
Founder and CEO
Have an account?